Abstract
Androgen signaling induces immunosuppression in cancer by blocking T-cell activity through upregulation of USP18 and subsequent inhibition of NF-κB activity, providing a targetable axis to improve antitumor immunity in males.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have